It is a pharma private limited company based in U T, Chandigarh, India, established in 2001.
2001 | U T, Chandigarh, India | ActiveKay Emm Biomedicals Private Limited, a active private limited company, was established on 10 September 2001 in U T, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232CH2001PTC024631. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a active non-compliant status. Its leadership includes Dimple Aggarwal (Director), Sanjay Aggarwal (Director), Rakhi Aggarwal (Director). It holds ₹3.25 Cr open charges and ₹1.87 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 70Sector 40 C Chandigarh, U T, Chandigarh, 160034.
U24232CH2001PTC024631
024631
10 September 2001
₹1.00 M
₹1.00 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Kay Emm Biomedicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dimple Aggarwal | Director | 10 Sep 2001 | Current |
| Sanjay Aggarwal | Director | 10 Sep 2001 | Current |
| Rakhi Aggarwal | Director | 10 Sep 2001 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kay Emm Biomedicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Kay Emm Biomedicals had a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹32,500,000.00
₹18,721,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2012 | Hdfc Bank Limited | ₹2.15 Cr | Open |
| 22 Mar 2004 | Bank Of Punjab Ltd. | ₹1.00 M | Open |
| 22 Mar 2004 | Centurian Bank Of Punjab Limited | ₹7.50 M | Open |
| 22 Mar 2004 | Bankofpunjabltd. | ₹2.50 M | Open |
| 15 Dec 2008 | Axis Bank Limited | ₹1.69 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Kay Emm Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kay Emm Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kay Emm Biomedicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kay Emm Biomedicals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Kay Emm Biomedicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Progress on A charge with Hdfc Bank Limited of Rs. 21.50 M registered on 25 Jun 2012 with Charge ID 10368484 was modified on 22 Jul 2013. was documented.
A charge registered on 15 Dec 2008 via Charge ID 10140976 with Axis Bank Limited was fully satisfied on 22 Nov 2012. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 21.50 M with Charge ID 10368484 was registered on 25 Jun 2012. was documented.
Progress on A charge registered on 10 Apr 2002 via Charge ID 90174067 with Punjab National Bank was fully satisfied on 23 Mar 2012. was documented.
The CIN of Kay Emm Biomedicals Private Limited is U24232CH2001PTC024631.
Kay Emm Biomedicals Private Limited is headquartered at Sco 70Sector 40 C Chandigarh, U T, Chandigarh, 160034.
Kay Emm Biomedicals Private Limited was incorporated on 10 September 2001.
The current directors of Kay Emm Biomedicals Private Limited are
The primary industry of Kay Emm Biomedicals Private Limited is Trade.
Kay Emm Biomedicals Private Limited is unlisted.
The authorized capital of Kay Emm Biomedicals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Kay Emm Biomedicals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX